Unknown OBSERVATIONAL NCT04256577

Serum Ceramides Level in Systemic Lupus Erythematosus (SLE) Patients as a Novel Marker for Renal Impairment

Sponsor: Assiut University

Interventions serum ceramides level in blood

Updated 5 times since 2020 Last updated: Feb 12, 2020 Started: Feb 29, 2020 Primary completion: Feb 28, 2021 Completion: Jun 30, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Systemic Lupus and is currently ongoing. Assiut University leads this study, which shows 5 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2022 — Jul 2024 [monthly]

Unknown Status

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Jan 2022 [monthly]

Not Yet Recruiting
Mar 2020 — Jan 2021 [monthly]

Not Yet Recruiting

First recorded

Feb 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assiut University

Data source: Assiut University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.